EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Carcinoid Heart Disease: Pathophysiology, Pathology, Clinical Manifestations, and Management

Chengyue Jin, Ajay Nair Sharma, Balasingam Thevakumar, Muhammad Majid, Shahad Al Chalaby, Nene Takahashi, Ashraf Tanious, Aro Daniela Arockiam, Neil Beri, Ezra A Amsterdam

Cardiology · 2021 · 146 (1) · 65-73

DOI: 10.1159/000507847 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiology, online erschienen am 16.10.2020. Verfasst von Chengyue Jin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Internal Medicine, University of California (Davis) Medical Center, Sacramento, California, USA. Hauptthemen laut MEDLINE: Carcinoid Heart Disease, Heart Valve Diseases, Pathology, Clinical, Pulmonary Valve Insufficiency. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carcinoid heart disease (CHD) is a rare and potentially lethal manifestation of an advanced carcinoid (neuroendocrine) tumor. The pathophysiology of CHD is related to vasoactive substances secreted by the tumor, of which serotonin is most prominent in the pathophysiology of CHD. Serotonin stimulates fibroblast growth and fibrogenesis, which can lead to cardiac valvular fibrosis. CHD primarily affects right heart valves, causing tricuspid and pulmonic regurgitation and less frequently stenosis of these valves. Left heart valves are usually spared because vasoactive substances such as serotonin are enzymatically inactivated in the lung vasculature. The pathology of CHD is characterized by plaque-like deposition of fibrous tissue on valvular cusps, leaflets, papillary muscles, chordae, and ventricular walls. Symptomatic CHD usually presents between 50 and 70 years of age, initially as dyspnea and fatigue. Echocardiography is the mainstay of imaging and demonstrates thickened right heart valves with limited mobility and regurgitation. Treatment focuses on control of the underlying carcinoid syndrome, targeting subsequent valvular heart disease and managing consequent heart failure. Surgical valve replacement and catheter-directed valve procedures may be effective for selected patients with CHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoid Heart DiseaseHeart Valve DiseasesPathology, ClinicalPulmonary Valve InsufficiencyHeart ValvesHumans

Stichwörter der Autor:innen

CarcinoidCarcinoid heart diseaseCarcinoid syndromeManagementPathophysiology

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Department of Internal Medicine, University of California (Davis) Medical Center, Sacramento, California, USA.
  • Division of Cardiovascular Medicine, Department of Internal Medicine, University of California (Davis) Medical Center, Sacramento, California, USA, eaamsterdam@ucdavis.edu.

Zitieren

APA

Jin, C., Sharma, A. N., Thevakumar, B., Majid, M., Al Chalaby, S., Takahashi, N., Tanious, A., Arockiam, A. D., Beri, N., & Amsterdam, E. A. (2021). Carcinoid Heart Disease: Pathophysiology, Pathology, Clinical Manifestations, and Management. Cardiology, 146(1), 65-73. https://doi.org/10.1159/000507847

Vancouver

Jin C, Sharma AN, Thevakumar B, Majid M, Al Chalaby S, Takahashi N, et al. Carcinoid Heart Disease: Pathophysiology, Pathology, Clinical Manifestations, and Management. Cardiology. 2021;146(1):65-73. doi:10.1159/000507847

BibTeX
@article{Jin2021,
  author = {Jin, Chengyue and Sharma, Ajay Nair and Thevakumar, Balasingam and Majid, Muhammad and Al Chalaby, Shahad and Takahashi, Nene and Tanious, Ashraf and Arockiam, Aro Daniela and Beri, Neil and Amsterdam, Ezra A},
  title = {Carcinoid Heart Disease: Pathophysiology, Pathology, Clinical Manifestations, and Management},
  journal = {Cardiology},
  year = {2021},
  volume = {146},
  number = {1},
  pages = {65--73},
  doi = {10.1159/000507847}
}
Kostenlos starten →